+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Treatment of acute coronary syndrome with GLP-1

Treatment of acute coronary syndrome with GLP-1

Official Gazette of the United States Patent & Trademark Office Patents 1280(3), Mar 16

The invention relates to methods for treating a patient suffering from acute coronary syndrome, but who is not suffering from a Q-wave myocardial infarction, comprising administration of a therapeutically effective amount of a GLP-1 molecule. The GLP-1 can be self-administered, and can be administered in one or more doses, as needed, on an intermittent or continuous basis, to optimize metabolism in cardiac tissue and to prevent cardiac damage associated with ischemia.

(PDF emailed within 1 workday: $29.90)

Accession: 035980754

Download citation: RISBibTeXText

Related references

Acute coronary syndrome emergency treatment strategies: Improved treatment and reduced mortality in patients with acute coronary syndrome using guideline-based critical care pathways. American Heart Journal 157(1): 61-68, 2009

Walking Beyond the GRACE Global Registry of Acute Coronary Events Model in the Death Risk Stratification During Hospitalization in Patients With Acute Coronary Syndrome What Do the AR-G ACTION Acute Coronary Treatment and Intervention Outcomes Network. 2013

Epidemiology, treatment and prognosis of acute coronary syndrome in Silesia. Outcomes of pilot project of the National Registry of Acute Coronary Syndrome PL-ACS. Kardiologia Polska 62 Suppl 1: I22-I27, 2009

Underuse of evidence-based treatment modalities in diabetic patients with non-ST elevation acute coronary syndrome. A prospective nation wide study on acute coronary syndrome (FINACS). Diabetes Research and Clinical Practice 61(1): 39-48, 2003

Bleeding and outcome in acute coronary syndrome: insights from continuous electrocardiogram monitoring in the Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) Trial. American Heart Journal 156(4): 769-775, 2008

Treatment results of patients with acute coronary syndrome. Data form the National Registry of Acute Coronary Syndrome PL-ACS. Kardiologia Polska 62 Suppl 1: I34-I38, 2009

Hemorrhagic stroke after percutaneous coronary interventions (PCI) with coronary Stents in patients with acute coronary syndrome (ACS): Results from the registry of Japan acute coronary syndrome study (JACSS). 2007

The causes and outcomes of inadequate implementation of existing guidelines for antiplatelet treatment in patients with acute coronary syndrome: the experience from Taiwan Acute Coronary Syndrome Descriptive Registry (T-ACCORD Registry). Clinical Cardiology 33(6): E40-E48, 2010

Factors Associated With Initial Prasugrel Versus Clopidogrel Selection for Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Insights From the Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study. Journal of the American Heart Association 5(9): -, 2016

Register of acute coronary syndromes in Russia: treatment and in hospital outcomes in non-ST elevation acute coronary syndrome. Kardiologiia 43(12): 23-36, 2003

In-hospital and 12-month outcomes after acute coronary syndrome treatment in patients aged<40 years of age (from the Polish Registry of Acute Coronary Syndromes). American Journal of Cardiology 114(2): 175-180, 2014

Treatment of acute coronary syndrome: Part 1: Non-ST-segment acute coronary syndrome. Critical Care Medicine 39(10): 2346-2353, 2011

Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trial. Lancet 361(9360): 809-813, 2003

Differences in the mode of presentation for acute coronary syndrome by pre-hospitalization medication, in relation to coronary risk factors, East-Osaka acute coronary syndrome (EACS) registry. Atherosclerosis 219(1): 355-360, 2012